{"id":312902,"date":"2017-05-09T14:58:21","date_gmt":"2017-05-09T18:58:21","guid":{"rendered":"https:\/\/www.sciencedaily.com\/releases\/2017\/05\/170509145821.htm"},"modified":"2017-05-09T14:58:21","modified_gmt":"2017-05-09T18:58:21","slug":"avastin-as-effective-as-eylea-for-treating-central-retinal-vein-occlusion","status":"publish","type":"post","link":"https:\/\/spaceweekly.com\/?p=312902","title":{"rendered":"Avastin as effective as Eylea for treating central retinal vein occlusion"},"content":{"rendered":"<p>Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion (CRVO), according to a clinical trial. After six monthly injections, treatment with either drug improved visual acuity on average from 20\/100 to 20\/40. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion (CRVO), according to a clinical trial. After six monthly injections, treatment with eith&#8230;<\/p>\n","protected":false},"author":61,"featured_media":615444,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-312902","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/posts\/312902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/users\/61"}],"replies":[{"embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=312902"}],"version-history":[{"count":1,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/posts\/312902\/revisions"}],"predecessor-version":[{"id":312903,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/posts\/312902\/revisions\/312903"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/media\/615444"}],"wp:attachment":[{"href":"https:\/\/spaceweekly.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=312902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=312902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=312902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}